T donors who are associated with TRALI events and how to reduce the risk of TRALI for
recipients of blood products. To address these issues, a Consensus Conference was …

Background: Transfusion-related acute lung injury (TRALI) is now the leading cause of
transfusion-associated mortality, even though it is probably still underdiagnosed and …

In recent years, transfusion‐related acute lung injury (TRALI) has developed from an almost
unknown transfusion reaction to the most common cause of transfusion‐related major …

The main indication for the transfusion of plasma is to correct deficiencies of clotting factors,
for which a specific concentrate is not available, in patients with active bleeding. The …

The objective of this review is to present the two-event model of transfusion-related acute
lung injury (TRALI), a life-threatening complication of transfusions that has been the most …

Careful assessment of risks and benefits has to precede each decision on allogeneic red
blood cell (RBC) transfusion. Currently, a number of key issues in transfusion medicine are …

Background Primary graft dysfunction (PGD) is the main cause of early morbidity and
mortality after lung transplantation. Previous studies have yielded conflicting results for PGD …

Transfusion-related acute lung injury is a relatively uncommon transfusion-associated
adverse effect occurring during or soon after an allogeneic blood transfusion. Transfusion …

BACKGROUND: This case series summarizes our observations of hemolytic reactions after
the administration of large amounts of intravenous immune (gamma) globulin (IVIG). STUDY …

Transfusion‐related acute lung injury (TRALI) is the leading cause of transfusion‐related
morbidity and mortality world‐wide. Although first described in 1983, it took two decades to …